Riluzole

1 clinical trials involving this therapy/drug

This is not medical advice - consult your oncologist

Descriptions are automatically translated with AI assistance. Always verify details in the original on ClinicalTrials.gov and consult your treating physician.

RecruitingPhase IIBreast cancerLung cancerOvarian cancerColorectal cancerGastric cancerPancreatic cancerLiver cancerLymphomaLeukemiaMelanomaProstate cancerKidney cancerBladder cancerHead and neck cancerGlioma (brain cancer)Other cancers

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

NCT06580002ClinicalTrials.gov ↗

This is a phase 2a, randomized, double-blinded, placebo-controlled pilot clinical trial determining the impact of riluzole therapy on circulating brain derived neuropathic factor (BDNF) levels in cancer survivors (recently completing prior treatment regimens) or patients who have received whole brain radiation for benign or malignant tumors with cancer related cognitive impairment.

Full details →

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.